Apollo Hospitals Enterprise Limited vs Neuland Laboratories Limited

A side-by-side comparison of Apollo Hospitals Enterprise Limited (APOLLOHOSP) and Neuland Laboratories Limited (NEULANDLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Apollo Hospitals Enterprise Limited leads APOLLOHOSP vs NEULANDLAB on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability13
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

APOLLOHOSP takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

58.43
P/E ratio
70.97
13.46
P/B ratio
16.30
0.22%
Dividend yield
0.14%
₹135.04
EPS
₹283.71

Profitability

NEULANDLAB takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

20.48%
Return on equity
19.42%
17.31%
Return on capital
23.57%
14.94%
EBITDA margin
28.40%
7.94%
Net margin
17.99%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
19.31%
33.35%
Profit CAGR (3Y)
30.57%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.14L Cr
Market cap
₹25,275 Cr
₹25,229 Cr
Revenue
₹2,023 Cr
₹2,003 Cr
Net profit
₹364 Cr
0.90
Debt / equity
0.16
Apollo Hospitals Enterprise Limited
  • + ["Company has delivered good profit growth of 71.0% CAGR over last 5 years", "Company has delivered good sales growth of 19.0% CAGR over last 5 years"]
  • − ["Stock is trading at 11.97 times its book value"]
Neuland Laboratories Limited
  • + ["Company has delivered good profit growth of 35.1% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 22.1%", "Company has delivered good sales growth of 16.6% CAGR over last 5 years"]
  • − ["Stock is trading at 13.47 times its book value"]
Apollo Hospitals Enterprise Limited full analysis Neuland Laboratories Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

APOLLOHOSP vs NEULANDLAB: Share Price, Valuation & Which to Buy | DocStoX